This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Systagenix Wound Management Limited
Systagenix Wound Management Limited, a leading name in the wound care industry, is headquartered in Great Britain. Founded in 2008, the company has established itself as a key player in the development of advanced wound management solutions, focusing on innovative products that enhance healing and improve patient outcomes. With a strong presence in Europe and North America, Systagenix offers a range of unique products, including advanced dressings and bioactive therapies, designed to address various wound types. Their commitment to research and development has led to significant milestones, positioning them as a trusted partner in healthcare. Recognised for their quality and efficacy, Systagenix continues to set industry standards, making substantial contributions to the field of wound management.
DitchCarbon Score
How does Systagenix Wound Management Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Systagenix Wound Management Limited's score of 69 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Systagenix Wound Management Limited, headquartered in Great Britain, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of 3M Company, and any climate commitments or emissions data may be inherited from this parent organization. As part of its corporate family relationship with 3M Company, Systagenix is aligned with several climate initiatives, including the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from 3M at a third-level relationship. However, specific reduction targets or achievements for Systagenix itself are not detailed in the available information. While Systagenix Wound Management Limited does not provide its own emissions data or reduction targets, it is important to note that the company is part of a broader commitment to sustainability and climate action through its association with 3M Company. This relationship may influence its future climate strategies and emissions reporting.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 157,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 111,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 2,229,960,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Systagenix Wound Management Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
